Lupin's Goa facility may face regulatory action, says USFDA
The USFDA has stated that it may withhold approval of any pending
applications or supplements in which this facility is listed," it
added.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/lupins-goa-facility-may-face-regulatory-action-says-usfda/articleshow/69586425.cms
applications or supplements in which this facility is listed," it
added.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/lupins-goa-facility-may-face-regulatory-action-says-usfda/articleshow/69586425.cms
Comments
Post a Comment